Erika J Schneble

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

EA Mittendorf, Guy T. Clifton, Jarrod P. Holmes et al. · Annals of Oncology · 2014 · 245 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice

Mihaela H. Bazalakova, James R. Wright, Erika J Schneble et al. · Genes Brain & Behavior · 2006 · 48 citations

Life Sciences, Neurobiology, Neuroscience +17

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

Julia M. Greene, Erika J Schneble, Doreen O. Jackson et al. · Cancer Immunology Immunotherapy · 2016 · 31 citations · Full text

Medicine, Immunology, Oncology +16

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation

John Berry, Alfred F. Trappey, Timothy J. Vreeland et al. · Journal of Cancer · 2015 · 24 citations · Full text

Medicine, Oncology, Pathology +17

Primary analysis of the prospective, randomized, phase II trial of GP2+GM-CSF vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.

Erika J Schneble, Sonia A. Perez, James L. Murray et al. · Journal of Clinical Oncology · 2014 · 15 citations

Medicine, Immunology, Oncology +17